Growth Hormone and IGF-1: What They Are and Their Connection to Aging

With each passing decade, the 'anti-aging' industry adopts a new molecule and crowns it as the 'fountain of youth'. One molecule that has repeatedly earned this title is growth hormone. The logic sounds compelling: when we were young, our bodies produced it in abundance, we grew and grew stronger, and with age, its levels plummet. So why not simply restore it to youthful levels and turn back time?

The problem is that when you examine the biology in depth, one of the most intriguing paradoxes in all of aging science emerges. Across entire species, from worm to human, a lower growth signal is actually linked to longer lives, not shorter ones. The hormone that builds us and repairs us is also, ironically, one of the factors that accelerates aging. To understand why, we first need to get to know the players.

In this article, we will explain what growth hormone and its partner IGF-1 are, show how they function as a single axis, dive into the paradox with the real studies behind it, and critically examine the attempt to sell growth hormone injections as an anti-aging treatment. Finally, we will see what actually helps maintain a healthy axis, and why 'moderate' beats 'maximal' precisely here.

What are Growth Hormone and IGF-1?

Growth hormone, scientifically known as somatotropin (GH), is a hormone secreted by the pituitary gland at the base of the brain. It does not flow at a constant level but rather in pulses (pulsatile), waves of secretion throughout the day. The largest and most consistent pulse occurs shortly after the onset of sleep, during the slow-wave sleep stage, and additional pulses arise after strenuous physical activity. Here are the players in brief:

• Growth Hormone (GH): Secreted from the pituitary gland in pulses, mainly during deep sleep and after exertion. Up to about 70% of daily secretion is tied to the first sleep pulse.
• IGF-1 (Insulin-like Growth Factor 1): Most of it is produced in the liver in response to GH, and it is the one that actually performs most of the anabolic work in tissues.
• The GH/IGF-1 Axis: The two function as a linked pair. GH is the signal from above, IGF-1 is the executor on the ground. Blood levels of IGF-1 are more stable than GH levels (which vary from pulse to pulse), so tests usually measure IGF-1 to assess axis activity.

What do they do? The GH/IGF-1 axis is the body's engine for growth and repair. IGF-1 signals cells to divide and grow, builds muscle and bone mass, promotes tissue repair, and affects the metabolism of fat and sugar. In childhood and adolescence, it drives height growth. In adulthood, it continues to maintain the body, but with diminishing intensity.

The Decline with Age: The Somatopause

GH and IGF-1 levels are not constant throughout life. They are very high in childhood, peak during adolescence, and then steadily decline with age. This gradual decline during adulthood has been termed the 'somatopause', paralleling how 'menopause' describes the decline of sex hormones.

This decline is real and measurable, and this is precisely where 'anti-aging' marketing steps in. The logical leap that private clinics make is seemingly simple: if the hormone declines with age, and if it is high in youth, then restoring it to youthful levels will restore youth. This is exactly the assumption that the paradox below overturns. The decline in the axis is not just passive 'wear and tear' to be fixed; it is part of a complex mechanism where less growth signal may actually be protective.

The Longevity Paradox: Why Less is More

Here lies the heart of the story, and one of the most robust and surprising findings in aging science. The insulin/IGF-1 signaling pathway is one of the 'master regulators' of the aging rate and belongs to one of the 12 hallmarks of aging: nutrient sensing dysregulation. And the direction is surprising: reducing this growth signaling extends lifespan across vastly different species.

Study 1: The Worm that Lived Twice as Long, 1993

In 1993, Cynthia Kenyon and colleagues published a paper in Nature that shook the field, titled 'A C. elegans mutant that lives twice as long as wild type'. A mutation in the daf-2 gene, which is the insulin/IGF-1 receptor in the worm C. elegans, doubled the worm's lifespan. Adult, active, fertile worms lived more than twice as long as normal. This was the largest lifespan extension reported at the time in any organism, and it required the activity of a second gene, daf-16. This finding placed the IGF-1 axis at the center of aging research and ignited the entire field.

Study 2: The Long-Lived Dwarf Mice, 1996

Three years later, in 1996, Holly Brown-Borg and colleagues published a paper in Nature titled 'Dwarf mice and the ageing process'. Ames dwarf mice, whose pituitary gland is defective and who lack growth hormone and IGF-1, are among the longest-lived mice in the lab. They lived about a year longer than their normal siblings, an extension of about 50% in lifespan. The extension was even greater in females, and both average and maximum lifespan increased significantly in both sexes. In other words: mice with less growth hormone live longer.

Study 3: Laron Syndrome, The Humans of the Paradox, 2011

But what about humans? This is where one of the most fascinating observations in medicine comes in. Laron syndrome is a rare genetic condition where the growth hormone receptor is defective, so the body produces GH but cannot respond to it, and IGF-1 levels are very low throughout life. Those affected are extremely short in stature.

In 2011, Jaime Guevara-Aguirre and colleagues published a study in Science Translational Medicine that followed a group of about 99 people with Laron syndrome from a rural community in Ecuador for about 22 years. The finding was extraordinary: almost none of them developed diabetes, and only one developed cancer, a non-fatal case. This was despite many of them living a rather unhealthy lifestyle. Their close relatives without the mutation developed cancer and diabetes at normal rates. The lifelong low IGF-1 levels were linked to cellular protection against cancer and age-related diseases.

Study 4: Low IGF-1 and Survival in Long-Lived Elderly, 2014

Finally, a link was also found in a general population of long-lived individuals. In 2014, Sofiya Milman and colleagues published a study in Aging Cell on 184 people aged ninety and over. Among women, those with IGF-1 levels below the median (about 96 ng/mL and below) survived significantly longer (P less than 0.01) compared to women with higher levels. Interestingly, the effect was found in women but not in men, a hint that sex hormones play a role in how the axis affects longevity.

The common thread across these four studies is clear. This is a 'trade-off' between growth and longevity: more growth signaling pushes the cell to grow, divide, and prioritize building over repair, and this is precisely what accelerates aging. Less growth signaling shifts the cell into a 'maintenance' state: DNA repair, internal cleaning (autophagy), and stress resistance. This is exactly why caloric restriction, which lowers this axis, extends lifespan in almost every organism tested.

The Critique of 'Anti-Aging' HGH Injections

If we understand the paradox, the obvious question is: what exactly are the 'anti-aging' clinics that sell growth hormone injections based on? The answer is a single, famous study from 1990.

Daniel Rudman and colleagues published a study in the New England Journal of Medicine on 21 men aged 61 to 81. Twelve of them received growth hormone for six months. The results sounded dramatic: an 8.8% increase in lean body mass, a 14.4% decrease in fat mass, and a 1.6% increase in bone density in the lumbar vertebrae. These numbers are the fuel for an entire industry. But there is a big problem here, even bigger than it seems.

First, a change in body composition is not the same as an improvement in function or health. Muscle mass that increases in numbers is not necessarily stronger or more functional muscle. And second, and this is decisive: larger, later systematic reviews reversed the picture.

In 2007, Hau Liu and colleagues from Stanford University published a systematic review in the Annals of Internal Medicine of growth hormone studies in healthy elderly people, including 220 participants. The conclusion was unequivocal: growth hormone causes only small changes in body composition, accompanied by a high rate of side effects, and cannot be recommended as an anti-aging treatment. The documented side effects included edema, joint pain (arthralgia), carpal tunnel syndrome, breast tissue development in men (gynecomastia), and insulin resistance that can lead to diabetes. In other words, the same hormone that is supposed to 'rejuvenate' actually pushes the body metabolically toward age-related diseases.

And there is another layer here that joins the paradox. Epidemiological studies link high IGF-1 levels to an increased risk of several types of cancer, including prostate and breast cancer. Meta-analyses have found about a 15% increase in overall cancer risk, and an odds ratio of around 1.3 for prostate cancer among those with high IGF-1. This connection makes sense, as IGF-1 is by definition a signal that encourages cells to divide and suppresses programmed cell death, precisely the traits a cancer cell 'likes'. It also nicely complements the findings from Laron syndrome: very low IGF-1 levels mean protection against cancer.

It is important to emphasize: growth hormone is a prescription drug, approved only for genuine medical conditions of growth hormone deficiency (e.g., children with confirmed deficiency, or adults with damage to the pituitary gland). Its use as an 'anti-aging treatment' in a healthy person is off-label, unproven, carries risks, and in the United States, it is even illegal to distribute it for this purpose. This is not an article explaining how to obtain or take it, but quite the opposite.

How to Support a Healthy GH/IGF-1 Axis, Naturally

If artificially restoring the hormone is not the solution, what is? The key is to understand that the goal is not to 'maximize' the axis but to maintain it healthy and appropriate for your age, while preserving the delicate balance between growth and maintenance. Here are the most powerful natural stimuli:

1. Physical Activity, Especially Resistance Training and Intense Exertion: Physical exertion is one of the most powerful natural stimuli for a growth hormone pulse, and it also builds muscle and improves insulin sensitivity, giving you the anabolic benefits without the negative sides of hormonal overdose.
2. Deep, Quality Sleep: Most of the daily growth hormone secretion occurs during the first pulse of deep sleep. Poor sleep robs you of this crucial pulse. Regular sleep hours, a dark and cool room, and avoiding screens before bed support it.
3. Adequate Protein in the Diet: Adequate protein intake supports IGF-1 production and muscle building, especially with age when the risk of sarcopenia (muscle loss) increases. But again, the word is 'adequate', not 'maximal'.

Note the honest nuance: Because of the trade-off between growth and longevity, the goal is not to push the axis to the limit. A healthy person does not want the IGF-1 levels of a teenager, but a functioning axis that supports muscle, bone, and repair without pushing the entire body into a constant 'growth' state. Exercise and sleep provide exactly this balance: local and functional stimulation, not hormonal flooding.

If you want a practical plan, our training plan builder (link below) will build you a strength and cardio routine for longevity, and the personal protocol builder integrates diet, activity, and sleep into one plan.

What to Actually Take from the Research?

1. If you have been offered growth hormone injections as an 'anti-aging treatment', stop and consult a doctor. The hormone is only approved for verified medical deficiency, and its anti-aging use is unproven and carries real risks.
2. Internalize the paradox: in aging biology, more growth signal is not better. Low to moderate IGF-1 levels are linked to longevity and less cancer and diabetes.
3. Invest in natural stimuli: resistance training, aerobic exercise, deep sleep, and moderate protein support a healthy axis without the risks of injections.
4. If you suspect a genuine deficiency (e.g., after surgery or damage to the pituitary gland), this is a medical question for an endocrinologist, not a decision for a beauty clinic.

The Broader Perspective

The story of growth hormone is a perfect example of how intuition about aging can be misleading. It seems logical to restore what time has taken, but the biology is more complex. The hormone that builds us in youth is also the one that accelerates the aging clock when too active, and this is the same principle that repeats itself throughout longevity science: mechanisms that are beneficial in the short term can be harmful in the long term. This is precisely the logic of 'antagonistic pleiotropy' within the framework of the 12 hallmarks of aging.

The bottom line: GH and IGF-1 build and repair, but when it comes to aging, less is often better, and a lower growth signal is linked to longer lives. Chasing growth hormone injections to 'reverse age' is a move contrary to science, dangerous, and unproven. The real levers are simple, accessible, and free: physical activity, deep sleep, and sensible protein. Not a fountain of youth in a vial, but habits that respect the balance the body itself knew how to maintain.

Note: This article is for educational and scientific purposes only and does not constitute medical advice. Growth hormone is a prescription drug, and using it without a proper medical diagnosis and a doctor's supervision is dangerous. Any decision regarding diagnosis, medications, supplements, or lifestyle changes should be made in consultation with a qualified physician.

Internal Links:
12 Hallmarks of Aging: Why We Age, The Complete Guide
How to Slow Aging: Solutions and Research for the 12 Hallmarks
Longevity Training Plan Builder
Personal Protocol Builder

References:
Science Translational Medicine, Guevara-Aguirre et al., 2011: Growth Hormone Receptor Deficiency and Reduced Pro-Aging Signaling
Nature, Kenyon et al., 1993: A C. elegans mutant that lives twice as long as wild type
Nature, Brown-Borg et al., 1996: Dwarf mice and the ageing process
Aging Cell, Milman et al., 2014: Low IGF-1 level predicts survival in humans with exceptional longevity
Annals of Internal Medicine, Liu et al., 2007: The Safety and Efficacy of Growth Hormone in the Healthy Elderly
New England Journal of Medicine, Rudman et al., 1990: Effects of Human Growth Hormone in Men over 60 Years Old